Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2022-02-22
2022-11-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Guided Biopsy for Mapping Prostate Cancer
NCT01007214
Prostate Cancer Screening With Abbreviated MRI Protocol
NCT05603351
A Prospective, Single-centre，Single-blinded Study of PROUD for Prostate Carcinoma Diagnosis
NCT04699344
Non-Invasive Biomarkers in Prostate Cancer Disease Management
NCT06144619
Characterization of Prostate Cancer With 3T MR
NCT00831142
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Evaluation of prostate cancer margins
Evaluation of prostate cancer margins
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject must be scheduled for robotic-assisted radical prostatectomy at the clinical site.
Exclusion Criteria
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Intuitive Surgical
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jörn Hinrich Witt, PD Dr. med
Role: PRINCIPAL_INVESTIGATOR
St. Antonius, Hospital, Prostatazentrum Nordwest, Möllenweg 22, 48599 Gronau, Germany
Sami-Ramzi Leyh-Bannurah, PD Dr. med
Role: PRINCIPAL_INVESTIGATOR
St. Antonius, Hospital, Prostatazentrum Nordwest, Möllenweg 22, 48599 Gronau, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St. Antonius Hospital, Prostatazentrum Nordwest
Gronau, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1091459C
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.